Ionis Pharma (IONS) Reports Q2 Loss of $0.09/Share

Ionis Pharma (NASDAQ: IONS) reported Q2 EPS of ($0.09), versus ($0.47) reported last year. Revenue for the quarter came in at $104.2 million, versus $38.5 million reported last year.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Hermès can regain momentum despite China weakness, Jefferies says